Skip to main content
PG

Precision Genetics

The startup provides lab services that integrate genetic markers, molecular data, and clinical evidence to generate personalized health reports. This enables healthcare providers to create tailored treatment and prevention plans based on individual genetic profiles, demographics, and medical histories.

Greenville, United StatesFounded 2017281K+ followers
Updated 3 months ago

Funding

$1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Clinicians often rely on trial and error when prescribing medications, particularly for mental health and post-operative pain management, leading to adverse drug reactions, prolonged recovery times, and increased healthcare costs. A lack of personalized treatment plans based on individual genetic profiles can result in ineffective medication choices and dosages.

Solution

Precision Genetics offers pharmacogenomic (PGx) testing and analysis to enable healthcare providers to create personalized medication management plans. By integrating a patient's genetic markers with molecular data and clinical evidence, Precision Genetics delivers actionable reports and clinical decision support. The company's solutions, including Neuropharmagen® for mental health and PrecisionOp for perioperative risk assessment, help providers identify safer, more effective medications and dosages, reducing adverse drug reactions and improving patient outcomes. Precision Genetics' Aina platform integrates seamlessly into existing EMR and LIMS systems, providing a comprehensive solution for personalized medicine.

Target Audience

The primary target audience includes healthcare providers, such as physicians, psychiatrists, and surgeons, seeking to improve patient outcomes and reduce healthcare costs through personalized medication management, as well as clinical laboratories looking to expand their testing services.

Features

  • Pharmacogenomic testing for mental health (Neuropharmagen®) and perioperative pain management (PrecisionOp)
  • Aina platform for seamless integration with EMR and LIMS systems
  • Identification of genetic variants affecting drug metabolism
  • Personalized medication recommendations based on individual genetic profiles
  • Analysis of drug-drug interactions, chronic diseases, comorbidities, and lifestyle factors
  • Tactical medication calculator designed for surgeons and the surgical experience
  • CLIA-compliant laboratories performing molecular testing
  • Customizable interpretation engine for genetic and non-genetic panels
  • Secure portal integration for providers to access test results
This profile is AI-generated and may contain inaccuracies.